Pazopanib

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

38 Suppliers, 13 USDMF, 6 EU WC, 5 KDMF, 9 NDC API, 34 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

35 Suppliers

35 Suppliers

DOSSIERs // Finished Dosage Forms

41 Dossiers, 6 FDA Orange Book, 2 Europe, 2 Canada, 12 Australia, 2 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 200MG BASE, TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 15 Kerry, 12 Seppic, 11 Roquette, 10 Corel Pharma Chem, 10 BASF, 9 Gangwal Chemicals, 9 Microlex e.U, 9 Sigachi Industries, 6 Gangwal Healthcare, 6 Lonza Capsugel, 5 Ideal Cures Pvt Ltd, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Pharmatrans-Sanaq, 3 Kima Chemical, 3 DKSH, 3 DFE Pharma, 3 Prachin Chemical, 3 Vasa Pharmachem, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Nanjing Well Pharmaceutical, 2 The Dow Chemical Company, 2 Pluviaendo, 2 Actylis, 1 Clariant, 1 Nanjing Bold Chemical, 1 Boai NKY Pharmaceuticals Ltd, 1 Ingredion Pharma Solutions, 1 SPI Pharma, 1 Jai Radhe Sales, 1 Ulanqab Kema New Material, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 ACG Worldwide, 1 Qualicaps

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 29 Fillers, Diluents & Binders, 23 Controlled & Modified Release, 18 Disintegrants & Superdisintegrants, 18 Solubilizers, 17 Direct Compression, 14 Thickeners and Stabilizers, 13 Granulation, 11 Lubricants & Glidants, 10 Film Formers & Plasticizers, 8 Parenteral, 7 Co-Processed Excipients, 5 Coloring Agents, 5 Emulsifying Agents, 5 Topical, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Rheology Modifiers, 3 Surfactant & Foaming Agents, 3 Chewable & Orodispersible Aids

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

MARKET PLACE

2 APIs, 6 DOSSIERS // FDF

PATENTS

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 BioAnalytical Methods

1 BioAnalytical Methods

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 12 News

Approved Drug Products containing Pazopanib listed in the FDA Orange Book. Original Data : FDA Website

Pazopanib

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

38 Suppliers

13 USDMF

6 EU WC

5 KDMF

9 NDC API

34 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

INTERMEDIATES

35 Suppliers

DOSSIERs // Finished Dosage Forms

41 Dossiers

6 FDA Orange Book

2 Europe

2 Canada

12 Australia

2 South Africa

17 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 200MG BASE

TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

15 Kerry

12 Seppic

11 Roquette

10 Corel Pharma Chem

10 BASF

9 Gangwal Chemicals

9 Microlex e.U

9 Sigachi Industries

6 Gangwal Healthcare

6 Lonza Capsugel

5 Ideal Cures Pvt Ltd

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Pharmatrans-Sanaq

3 Kima Chemical

3 DKSH

3 DFE Pharma

3 Prachin Chemical

3 Vasa Pharmachem

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Nanjing Well Pharmaceutical

2 The Dow Chemical Company

2 Pluviaendo

2 Actylis

1 Clariant

1 Nanjing Bold Chemical

1 Boai NKY Pharmaceuticals Ltd

1 Ingredion Pharma Solutions

1 SPI Pharma

1 Jai Radhe Sales

1 Ulanqab Kema New Material

1 Qianhao Chemical (Hebei) Co., Ltd

1 ACG Worldwide

1 Qualicaps

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives

29 Fillers, Diluents & Binders

23 Controlled & Modified Release

18 Disintegrants & Superdisintegrants

18 Solubilizers

17 Direct Compression

14 Thickeners and Stabilizers

13 Granulation

11 Lubricants & Glidants

10 Film Formers & Plasticizers

8 Parenteral

7 Co-Processed Excipients

5 Coloring Agents

TABLET;ORAL - EQ 400MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

EQ 400MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons